Registry-based Stroke in Tunisia

NCT ID: NCT05325606

Last Updated: 2024-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

800 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-01

Study Completion Date

2025-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study the prevalence of strokes in the emergency department (ED) and their possible eligibility for thrombolysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The diagnosis and management of strokes represent a great emergency that requires multidisciplinary teams and an organization of the care chain from the collection of patients at the site of the stroke to follow-up care.

That is why it is necessary to identify the prevalence of stroke in the ED in Tunisia and to evaluate their eligibility for thrombolysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke, Ischemic Strokes Thrombotic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients with stroke symptoms.

Exclusion Criteria

* Refusal of inclusion
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Monastir

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pr. Semir Nouira

Professor, A head of Emmergency Departement in Monastir

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nouira Semir, Professor

Role: PRINCIPAL_INVESTIGATOR

University of Monastir

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nouira Semir

Monastir, , Tunisia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Tunisia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nouira Semir, Professor

Role: CONTACT

73106046 ext. +216

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nouira Semir, Professor

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Tunisia Stroke

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Blod Biomarkers for Stroke
NCT03941249 UNKNOWN